MOLECULAR DIAGNOSTICS & THERAPEUTICS INC
10QSB, EX-27, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MOLECULAR DIAGNOSTICS & THERAPEUTICS INC, 10QSB, 2000-08-14
Next: I TRAX COM INC, 10QSB, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5


<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              MAR-31-2001
<PERIOD-START>                                 APR-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                            9,687
<SECURITIES>                                          0
<RECEIVABLES>                                         0
<ALLOWANCES>                                          0
<INVENTORY>                                           0
<CURRENT-ASSETS>                                      0
<PP&E>                                          104,441
<DEPRECIATION>                                  (85,294)
<TOTAL-ASSETS>                                  146,565
<CURRENT-LIABILITIES>                            86,197
<BONDS>                                               0
                                 0
                                           0
<COMMON>                                      3,142,446
<OTHER-SE>                                   (3,082,078)
<TOTAL-LIABILITY-AND-EQUITY>                    146,565
<SALES>                                               0
<TOTAL-REVENUES>                                      0
<CGS>                                                 0
<TOTAL-COSTS>                                         0
<OTHER-EXPENSES>                                103,069
<LOSS-PROVISION>                                      0
<INTEREST-EXPENSE>                                    0
<INCOME-PRETAX>                                (103,069)
<INCOME-TAX>                                          0
<INCOME-CONTINUING>                            (103,069)
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                   (103,069)
<EPS-BASIC>                                       (0.01)
<EPS-DILUTED>                                     (0.01)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission